Excess cysteine drives conjugate formation and impairs proliferation of NRF2-activated cancer cells
Top Cited Papers
Open Access
- 7 April 2026
- journal article
- letter
- Published by Springer Nature in Nature Metabolism
- Vol. 8 (4) , 840-854
Abstract
Cancer cells with constitutive NRF2 activation take up excess cystine beyond the cysteine demands of conventional pathways, implying unknown metabolic fates. Here, we develop an unbiased approach for the identification of cysteine metabolic fates and find that both known and previously uncharacterized cysteine-derived metabolites accumulate in NRF2-activated cancer cells. We identify many of these unknown metabolites as conjugates formed between cysteine and endogenous sugar metabolites, which can also be generated in vitro. We confirm the presence of these cysteine-derived conjugates in murine lung cancer models and primary human lung cancer samples, and their enrichment in NRF2-activated tumours in each context. Mechanistically, NRF2 promotes cystine uptake by driving SLC7A11 expression, which increases intracellular cysteine levels to promote these cysteine fates in a panel of cancer cell lines. Finally, we show that NRF2 activation creates a sensitivity to high environmental cystine, which impairs cell proliferation through excess free cysteine, and can be mitigated by sequestration into cysteine-derived conjugates. Overall, these findings reveal a cancer-associated metabolic vulnerability to excess cysteine stress, and reveal unrecognized routes of cysteine metabolism.Keywords
Funding Information
- National Cancer Institute (P30CA015704)
- National Cancer Institute (R37CA230042)
- National Cancer Institute (P01CA250984)
- National Institute of General Medical Sciences (T32GM007270)
This publication has 60 references indexed in Scilit:
- NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancerCell Metabolism, 2023
- Metabolite discovery: Biochemistry’s scientific driverCell Metabolism, 2022
- Activation of Oxidative Stress Response in Cancer Generates a Druggable Dependency on Exogenous Non-essential Amino AcidsCell Metabolism, 2020
- Cysteine Toxicity Drives Age-Related Mitochondrial Decline by Altering Iron HomeostasisCell, 2020
- Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP SynthaseCell, 2017
- Understanding the Intersections between Metabolism and Cancer BiologyCell, 2017
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic ReprogrammingCancer Cell, 2012
- An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell CarcinomaCancer Cell, 2011
- Thiazolidine derivatives as source of free l-cysteine in rat tissueBiochemical Pharmacology, 1993
- Cytotoxicity of cysteine in culture mediaIn Vitro Cellular & Developmental Biology - Plant, 1976